MENU
+Compare
CHGCY
Stock ticker: OTC
AS OF
Sep 26 closing price
Price
$20.98
Change
-$0.91 (-4.16%)
Capitalization
69.54B

CHGCY Chugai Pharmaceutical Co., Ltd. Forecast, Technical & Fundamental Analysis

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company... Show more

CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CHGCY with price predictions
Sep 25, 2025

CHGCY saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for CHGCY moved out of overbought territory on September 11, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 43 similar instances where the indicator exited the overbought zone. In of the 43 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CHGCY as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CHGCY turned negative on September 25, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

CHGCY moved below its 50-day moving average on September 24, 2025 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for CHGCY moved below the 200-day moving average on August 22, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHGCY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The 10-day moving average for CHGCY crossed bullishly above the 50-day moving average on September 18, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHGCY advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

CHGCY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 203 cases where CHGCY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.173) is normal, around the industry mean (9.332). P/E Ratio (25.976) is within average values for comparable stocks, (23.208). CHGCY's Projected Growth (PEG Ratio) (4.089) is slightly higher than the industry average of (1.760). Dividend Yield (0.029) settles around the average of (0.029) among similar stocks. CHGCY's P/S Ratio (8.584) is very high in comparison to the industry average of (3.375).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CHGCY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHGCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
CHGCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

CHGCY paid dividends on April 12, 2024

Chugai Pharmaceutical Co., Ltd. CHGCY Stock Dividends
А dividend of $0.13 per share was paid with a record date of April 12, 2024, and an ex-dividend date of December 28, 2023. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsMajor

Profile
Fundamentals
Details
Industry
N/A
Address
1-1 Nihonbashi-Muromachi 2-Chome
Phone
+81 332816611
Employees
7432
Web
http://www.chugai-pharm.co.jp
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XERS8.180.33
+4.20%
Xeris Biopharma Holdings
FSTR27.540.83
+3.11%
L.B. Foster Company
LEGN33.370.55
+1.68%
Legend Biotech Corp
KLAC1064.295.19
+0.49%
KLA Corp
LITB1.90-0.18
-8.85%
LightInTheBox Holding Co Ltd

CHGCY and Stocks

Correlation & Price change

A.I.dvisor tells us that CHGCY and CHGCF have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHGCY and CHGCF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHGCY
1D Price
Change %
CHGCY100%
N/A
CHGCF - CHGCY
32%
Poorly correlated
N/A
OTSKY - CHGCY
30%
Poorly correlated
N/A
OPHLY - CHGCY
22%
Poorly correlated
N/A
DSNKY - CHGCY
22%
Poorly correlated
N/A
RHHBY - CHGCY
20%
Poorly correlated
N/A
More